Form 4 for SANA Sana Biotechnology, Inc.
Accepted 2025-01-03 00:00:00 ET · period of report 2025-01-02 · accession 0001562180-25-000105 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-03 | 2025-01-02 | SANA | Wyrick Susan D. | See Remarks | M - OptEx | $0.00 | +5,000 | 155.5K | +3% | $0 |
| D | 2025-01-03 | 2025-01-02 | SANA | Wyrick Susan D. | See Remarks | F - Tax | $1.65 | -1,566 | 153.9K | -1% | -$2,584 |
| D | 2025-01-03 | 2025-01-02 | SANA | Wyrick Susan D. | See Remarks | M - OptEx | $0.00 | -5,000 | 7,500 | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-02 | M | A | 5,000 | $0.00 | 155,512 | D | — | — | (F1) Includes 3,000 shares acquired on November 15, 2024 pursuant to Sana Biotechnology, Inc.'s ("Sana") 2021 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2025-01-02 | F | D | 1,566 | $1.65 | 153,946 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-01-02 | M | D | 5,000 | $0.00 | 7,500 | D | — · — to — | 5,000 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Sana common stock. (F3) The award vested as to 40% of the restricted stock units on January 2, 2025 and the remaining 60% of the restricted stock units will vest on January 2, 2026, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date. |